Review
doi: 10.1016/j.vaccine.2010.08.002.
Epub 2010 Aug 14.
TLR-based immune adjuvants
Affiliations
- PMID: 20713100
- PMCID: PMC3000864
- DOI: 10.1016/j.vaccine.2010.08.002
Item in Clipboard
Review
TLR-based immune adjuvants
Vaccine.
.
Abstract
This work describes the nature and strength of the immune response induced by various Toll-like receptor ligands and their ability to act as vaccine adjuvants. It reviews the various ligands capable of triggering individual TLRs, and then focuses on the efficacy and safety of those agents for which clinical results are available.
Published by Elsevier Ltd.
Similar articles
-
IABS international scientific workshop--Mode of Action of Adjuvants: implications for vaccine safety and design, April 29-30, 2010, Bethesda, MD, USA.Vaccine. 2011 Apr 12;29(17):3340. doi: 10.1016/j.vaccine.2011.02.015. Epub 2011 Feb 16. Vaccine. 2011. PMID: 21335035 No abstract available.
-
Adjuvants and delivery technologies.Hum Vaccin. 2009 Oct;5(10):667-70. doi: 10.4161/hv.5.10.9140. Epub 2009 Oct 1. Hum Vaccin. 2009. PMID: 19556878 No abstract available.
-
Vaccine adjuvant safety: the elephant in the room.Expert Rev Vaccines. 2013 Jul;12(7):715-7. doi: 10.1586/14760584.2013.811198. Expert Rev Vaccines. 2013. PMID: 23885815 No abstract available.
-
Mucosal adjuvants.Curr HIV Res. 2010 Jun;8(4):330-5. doi: 10.2174/157016210791208695. Curr HIV Res. 2010. PMID: 20353395 Review.
-
Non-human primates as a model for understanding the mechanism of action of toll-like receptor-based vaccine adjuvants.Curr Opin Immunol. 2017 Aug;47:1-7. doi: 10.1016/j.coi.2017.06.006. Epub 2017 Jul 15. Curr Opin Immunol. 2017. PMID: 28715767 Review.
Cited by
-
Cricket paralysis virus internal ribosome entry site-derived RNA promotes conventional vaccine efficacy by enhancing a balanced Th1/Th2 response.Vaccine. 2019 Aug 23;37(36):5191-5202. doi: 10.1016/j.vaccine.2019.07.070. Epub 2019 Jul 29. Vaccine. 2019. PMID: 31371226 Free PMC article.
-
A TLR4-derived non-cytotoxic, self-assembling peptide functions as a vaccine adjuvant in mice.J Biol Chem. 2018 Dec 21;293(51):19874-19885. doi: 10.1074/jbc.RA118.002768. Epub 2018 Nov 1. J Biol Chem. 2018. PMID: 30385503 Free PMC article.
-
Immunogenicity and Reactogenicity in Q Fever Vaccine Development.Front Immunol. 2022 May 26;13:886810. doi: 10.3389/fimmu.2022.886810. eCollection 2022. Front Immunol. 2022. PMID: 35693783 Free PMC article. Review.
-
Inflammasomes as Targets for Adjuvants.Pathogens. 2020 Mar 30;9(4):252. doi: 10.3390/pathogens9040252. Pathogens. 2020. PMID: 32235526 Free PMC article. Review.
-
Intranasal Immunization with DnaK Protein Induces Protective Mucosal Immunity against Tuberculosis in CD4-Depleted Mice.Front Cell Infect Microbiol. 2018 Feb 8;8:31. doi: 10.3389/fcimb.2018.00031. eCollection 2018. Front Cell Infect Microbiol. 2018. PMID: 29473022 Free PMC article.
References
-
- Janeway CA, Jr., Medzhitov R. Innate immune recognition. Annu Rev Immunol. 2002;20:197–216.. 197–216. - PubMed
-
- Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006 Feb 24;124(4):783–801. - PubMed
-
- Medzhitov R. Recognition of microorganisms and activation of the immune response. Nature. 2007 Oct 18;449(7164):819–26. - PubMed
-
- Pasare C, Medzhitov R. Toll-like receptors and acquired immunity. Semin Immunol. 2004 Feb;16(1):23–6. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
